Publication Details
GPs’ insights into prostate cancer diagnosis and care in regional Victoria, Australia
Ruseckaite R, Evans S, Millar J, Holton S, Mazza D, Fisher J, Kirkman M
(2016),
Qual Rep,
21(12),
Gleason group concordance between biopsy and radical prostatectomy specimens: A cohort study from Prostate Cancer Outcome Registry - Victoria
Evans SM, Patabendi Bandarage V, Kronborg C, Earnest A, Millar J, Clouston D
(2016),
Prostate Int,
4(4),
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease
Ruseckaite R, Beckmann K, O'Callaghan M, Roder D, Moretti K, Millar J, Evans S
(2016),
BMC Cancer,
16,
The normal tissue effects of microbeam radiotherapy: What do we know, and what do we need to know to plan a human clinical trial?
Smyth LM, Senthi S, Crosbie JC, Rogers PA
(2016),
Int J Radiat Biol,
92(6),
Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia
Ruseckaite R, Sampurno F, Millar J, Frydenberg M, Evans S
(2016),
BMC Urol,
16(1),
Two-dimensional scanning of PRESAGE® dosimetry using UV/VIS spectrophotometry and its potential application in radiotherapy
Youkahana EQ, Gagliardi F, Geso M
(2016),
Biomed Phys Eng Express,
2(4),
Comparison of patient-reported quality-of-life and complications in men with prostate cancer, between two modes of administration
Sampurno F, Ruseckaite R, Millar JL, Evans SM
(2016),
Clin Genitourin Cancer,
14(4),
Prospective evaluation of patient-reported quality of life outcomes after external beam radiation treatment for prostate cancer in Victoria: a cohort study by the Victorian Prostate Cancer Registry
Patabendi Bandarage VR, Billah B, Millar JL, Evans S
(2016),
J Med Imaging Radiat Oncol,
60(3),
Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria
Sampurno F, Earnest A, Kumari PB, Millar JL, Davis ID, Murphy DG, Frydenberg M, Kearns PA, Evans SM
(2016),
Med J Aust,
204(8),
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
Duchesne GM, Woo HH, Bassett JK, Bowe SJ, D'Este C, Frydenberg M, King M, Ledwich L, Loblaw A, Malone S, Millar J, Milne R, Smith RG, Spry N, Stockler M, Syme RA, Tai KH, Turner S
(2016),
Lancet Oncol,
17(6),
Limiting the risk of cardiac toxicity with esophageal-sparing intensity modulated radiotherapy for locally advanced lung cancers
Woodford K, Panettieri V, Ruben JD, Senthi S
(2016),
J Thorac Dis,
8(5),
A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking
Smith RL, Haworth A, Panettieri V, Millar JL, Franich RD
(2016),
Med Phys,
43(5),
Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
Jalilian M, Davis S, Mohebbi M, Sugamaran B, Porter IW, Bell S, Warrier SK, Wale R
(2016),
J Gastrointest Oncol,
7(4),
Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience
Ong WL, Nazareth L, Hindson B, Matheson B, Millar JL
(2016),
J Med Radiat Sci,
63(3),
Development of South Australian-Victorian prostate cancer health outcomes research dataset
Ruseckaite R, Beckmann K, O'Callaghan M, Roder D, Moretti K, Zalcberg J, Millar J, Evans S
(2016),
BMC Res Notes,
9,
Development of an International Prostate Cancer Outcomes Registry
Evans SM, Nag N, Roder D, Brooks A, Millar JL, Moretti KL, Pryor D, Skala M, McNeil JJ
(2016),
BJU Int,
117 Suppl 4,
HIV and renal cell carcinoma: experience in an Australian statewide HIV center
Ong WL, King K, Koh TL, Chipman M, Royce P, Hoy J, Millar JL
(2016),
Asia Pac J Clin Oncol,
12(2),
Eosinophil-associated gene pathways but not eosinophil numbers are differentially regulated between synchrotron microbeam radiation treatment and synchrotron broad-beam treatment by 48 hours postirradiation
Ibahim MJ, Yang Y, Crosbie JC, Stevenson A, Cann L, Paiva P, Rogers PA
(2016),
Radiat Res,
185(1),
Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques
Duchesne GM, Haworth A, Bone E, Carter H, Ebert MA, Gagliardi F, Gibbs A, Hornby C, Martin A, Sidhom M, Wood M, Jackson M
(2016),
J Med Imaging Radiat Oncol,
60(1),
Variation in lung tumour breathing motion between planning four-dimensional computed tomography and stereotactic ablative radiotherapy delivery and its dosimetric implications: any role for four-dimensional set-up verification?
Ruben JD, Seeley A, Panettieri V, Ackerly T
(2016),
Clin Oncol,
28(1),
